|
Index of reports
> Cases resulting in hospitalization (69)
Below is the selection of adverse event reports related to Amaryl (Glimepiride) that includes cases resulting in hospitalization.
Reports 1 - 25 of 69 Next >>
Adverse event in male receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-31
Patient: male
Adverse reactions / side effects: Abdominal Pain, Vomiting, Alanine Aminotransferase Increased, Liver Disorder, Malaise, Diarrhoea, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Anorexia, Cough
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-03-23
End date: 2007-07-03
Miglitol Tablet
Dosage: daily dose:150mg
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-01-27
End date: 2007-06-23
Other drugs received by patient: Glucobay; Valsartan; Lansoprazole; Lendormin; Glyburide
Adverse event in 60 year old female receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification on 2007-10-30
Patient: 60 year old female, weighing 83.0 kg (182.6 pounds)
Adverse reactions / side effects: Vitamin B12 Deficiency, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2003-10-04
Avandamet
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2005-06-30
End date: 2006-09-15
Avandia
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2005-02-21
End date: 2005-06-30
Glucophage
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2003-10-04
End date: 2007-04-02
Other drugs received by patient: Daflon / 00426001 /; Fosinopril Sodium and Hydrochlorothiazide; Detensiel / 00802601 /; Levothyrox; Kardegic / 00002703 /; Vasten / 00880402 /; Laroxyl
Adverse event in male receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-26
Patient: male
Adverse reactions / side effects: Abdominal Pain, Malaise, Diarrhoea, Gamma-Glutamyltransferase Increased, Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-03-23
End date: 2007-07-03
Miglitol Tablet
Dosage: daily dose:150mg
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-01-27
End date: 2007-06-23
Other drugs received by patient: Glucobay; Valsartan; Lansoprazole; Lendormin; Glyburide
Adverse event in 79 year old female receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification from France on 2007-10-23
Patient: 79 year old female
Adverse reactions / side effects: Confusional State, Vomiting, Blood Urea Increased, Nausea, Hypotension, Hypoglycaemia, Somnolence, Blood Creatinine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Actiskenan
Dosage: 10 mg/day
Administration route: Oral
Indication: Skin Ulcer
Start date: 2007-07-17
End date: 2007-07-18
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-11-01
End date: 2007-07-18
Lasix
Administration route: Oral
Voltaren
Dosage: 75 mg/day
Administration route: Oral
Indication: Pain
End date: 2007-07-18
Zofenil
Dosage: 30 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2006-11-01
End date: 2007-07-18
Other drugs received by patient: Levothyrox; Ginkor; Pyostacine; Acetaminophen; Forlax; Diffu K; Vitamin B-12; Sterogyl; Rivotril; Topalgic
Adverse event in 51 year old female receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from India on 2007-10-23
Patient: 51 year old female
Adverse reactions / side effects: Syncope, Hypoglycaemia, Loss of Consciousness
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: discontinued on 21-sep-2007 and again restarted on 01-oct-2007.
Administration route: Oral
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-08-01
Lantus
Dosage: discontinued on 21-sep-2007 and again restarted on 01-oct-2007.
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-08-01
Metformin HCL
Dosage: discontinued on 21-sep-2007 and again restarted on 01-oct-2007.
Administration route: Oral
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-08-01
Other drugs received by patient: Enalapril Maleate
Adverse event in 79 year old female receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification on 2007-10-17
Patient: 79 year old female
Adverse reactions / side effects: Confusional State, Vomiting, Nausea, Drug Intolerance, Hypoglycaemia, Hypotension, Somnolence, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Actiskenan
Administration route: Oral
Start date: 2007-07-17
End date: 2007-07-18
Amaryl
Administration route: Oral
Start date: 2006-11-01
End date: 2007-07-18
Voltaren
Administration route: Oral
End date: 2007-07-18
Zofenil
Administration route: Oral
Indication: Hypertension
Start date: 2006-11-01
End date: 2007-07-18
Other drugs received by patient: Levothyrox; Ginkor; Pyostacine; Efferalgan / 00020001 /; Lasix; Forlax; Diffu K; Vitamin B-12; Sterogyl / 00765501 /; Rivotril; Topalgic
Adverse event in 51 year old female receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-10-15
Patient: 51 year old female
Adverse reactions / side effects: Syncope, Hypoglycaemia, Loss of Consciousness
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-08-01
Lantus
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-08-01
Metformin HCL
Administration route: Oral
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-08-01
Other drugs received by patient: Enalapril Maleate
Adverse event in male receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-06
Patient: male
Adverse reactions / side effects: Abdominal Pain, Malaise, Diarrhoea, Gamma-Glutamyltransferase Increased, Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-03-23
End date: 2007-07-03
Miglitol Tablet
Dosage: daily dose:150mg
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-01-27
End date: 2007-06-23
Other drugs received by patient: Glucobay; Valsartan; Lansoprazole; Lendormin; Daonil
Adverse event in 57 year old male receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-10-03
Patient: 57 year old male
Adverse reactions / side effects: Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Actos
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-05-11
End date: 2007-07-17
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-05-11
End date: 2007-07-17
Aspirin
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2007-03-22
End date: 2007-07-17
Atelec
Administration route: Oral
Indication: Hypertension
Start date: 2007-03-23
End date: 2007-07-17
Candesartan Cilexetil
Administration route: Oral
Indication: Hypertension
Start date: 2007-03-23
End date: 2007-07-17
Depas
Administration route: Oral
Indication: Anxiety Disorder
Start date: 2007-06-06
End date: 2007-07-17
Miglitol
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-04-10
End date: 2007-07-17
Paxil
Administration route: Oral
Indication: Depression
Start date: 2007-06-06
End date: 2007-07-17
Pepcid RPD
Administration route: Oral
Indication: Gastritis
Start date: 2007-04-04
End date: 2007-07-17
Adverse event in 76 year old male receiving Amaryl (Glimepiride)
Reported by a pharmacist from Japan on 2007-07-24
Patient: 76 year old male
Adverse reactions / side effects: Protein Urine Present, Blood Urine Present, Systemic Lupus Erythematosus
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl (Glimepiride)
Other drugs received by patient: Basen; Amlodipine; Micardis; Ticlopidine HCL; Aspirin; Famotidine
Adverse event in 87 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-07-23
Patient: 87 year old female, weighing 35.0 kg (77.0 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Coagulopathy, Cholestasis, Coma, Hepatic Failure, Gastrointestinal Tube Insertion, Liver Disorder, Hepatic Encephalopathy, Subdural Haematoma, Malaise, Gamma-Glutamyltransferase Increased, Cholecystitis, Gallbladder Disorder, Prothrombin Time Ratio Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Tremor, Cholelithiasis, Anorexia, Aspartate Aminotransferase Increased, Gallbladder Polyp
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-04-01
End date: 2007-05-17
Aspirin
Dosage: 100 mg/day
Administration route: Oral
Indication: Angina Pectoris
Start date: 2007-04-01
End date: 2007-05-26
Diovan
Dosage: 40 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2006-06-14
End date: 2007-05-23
Norvasc
Dosage: 2.5 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 1999-05-01
End date: 2007-05-25
Other drugs received by patient: Roxatidine Acetate HCL; Nateglinide; Triazolam; Lisinopril; Lisinopril
Adverse event in 54 year old female receiving Amaryl (Glimepiride)
Reported by a pharmacist from Japan on 2007-07-20
Patient: 54 year old female
Adverse reactions / side effects: Thrombocytopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl (Glimepiride)
Other drugs received by patient: Basen; Amlodipine; Gluconsan K; Singulair; Theolong; Nipolazin; Pletal; Magmitt; Mucosta; Pravastatin Sodium; Meptin Minitab
Adverse event in 76 year old male receiving Amaryl (Glimepiride)
Reported by a pharmacist from Japan on 2007-07-17
Patient: 76 year old male
Adverse reactions / side effects: Protein Urine Present, Blood Urine Present
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl (Glimepiride)
Other drugs received by patient: Basen; Amlodin; Micardis; Ticlopidine HCL; Aspirin; Gaster
Adverse event in 84 year old male receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-07-13
Patient: 84 year old male
Adverse reactions / side effects: Hepatic Function Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
End date: 2007-07-03
Diovan
Dosage: 40 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2006-11-07
End date: 2007-07-03
Melbin
End date: 2007-07-03
Ticlopidine HCL
End date: 2007-07-03
Adverse event in 83 year old male receiving Amaryl (Glimepiride)
Reported by a consumer/non-health professional from United States on 2007-07-09
Patient: 83 year old male, weighing 98.0 kg (215.5 pounds)
Adverse reactions / side effects: Cardiac Flutter, Blood Glucose Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Actos
Dosage: 45 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-10-01
End date: 2007-06-01
Amaryl
Dosage: 4 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 1997-01-01
Glucophage
Dosage: 1000 mg, 2 in 1 d, per oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 1982-01-01
Other drugs received by patient: Unknown Insulin (Insulin); Toprol-XL
Adverse event in 54 year old female receiving Amaryl (Glimepiride)
Reported by a pharmacist from Japan on 2007-07-09
Patient: 54 year old female
Adverse reactions / side effects: Platelet Count Decreased, Idiopathic Thrombocytopenic Purpura
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl (Glimepiride)
Other drugs received by patient: Basen; Amlodin; Gluconsan K; Singulair; Theolong; Nipolazin; Pletal; Magmitt; Mucosta; Pravastatin Sodium; Meptin Minitab
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-07-03
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in male receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-07-02
Patient: male, weighing 79.7 kg (175.3 pounds)
Adverse reactions / side effects: Glycosylated Haemoglobin Increased, Blood Pressure Inadequately Controlled, Acute Respiratory Failure, Diabetes Mellitus Inadequate Control
Adverse event resulted in: hospitalization
Suspect drug(s):
Actos
Dosage: 15 mg (15 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2004-03-26
End date: 2007-03-29
Amaryl
Dosage: 8 mg (4 mg, 2 in 1 d), per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2002-03-01
End date: 2007-03-29
Amlodin (Amlodipine Besilate) (Tablet) (Amlodipine Besilate)
Dosage: 5 mg (5 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-02-05
Dibetos B (Buformin Hydrochloride) (Tablet) (Buformin Hydrochloride)
Dosage: 50 mg (50 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1995-10-12
End date: 2007-03-29
Isocline (Clotiazepam) (Clotiazepam)
Dosage: 15 mg, per oral
Administration route: Oral
Start date: 1995-02-27
End date: 2007-03-29
Olmetec
Dosage: 20 mg (20 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2006-02-10
End date: 2007-03-29
Adverse event in 60 year old male receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-06-14
Patient: 60 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Renal Failure, Intentional Overdose, Hyperglycaemia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Norvasc
Administration route: Oral
Other drugs received by patient: Actos; Basen; Mucosta; Gaster D; Diovan; Vitamedin / 00274301 /; Kerlong
Adverse event in 78 year old male receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification from France on 2007-06-11
Patient: 78 year old male
Adverse reactions / side effects: Urinary Tract Infection Enterococcal, Visual Disturbance, Hypoglycaemia, Asthenia, Cerebellar Syndrome, Tremor
Adverse event resulted in: hospitalization
Suspect drug(s):
Actos
Dosage: 1 df (1 df, 1 in 1 d) oral
Administration route: Oral
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-01-01
End date: 2007-03-28
Amaryl
Dosage: 6 mg (6 mg, 1 in 1 d) oral
Administration route: Oral
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-01-01
End date: 2007-03-28
Other drugs received by patient: BI Tildem (Diltiazem Hydrochloride); Cotareg (Hydrochlorothiazide, Valsartan)
Adverse event in male receiving Amaryl (Glimepiride)
Reported by a consumer/non-health professional from United States on 2007-06-07
Patient: male, weighing 102.1 kg (224.6 pounds)
Adverse reactions / side effects: Drug Ineffective, Stomach Discomfort, Visual Acuity Reduced, Headache, Weight Increased, Anxiety, Anorexia, Atrioventricular Block, Asthenia, Feeling Abnormal, Myocardial Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Indication: Blood Glucose Increased
Start date: 2005-01-01
End date: 2007-05-15
Avandia
Indication: Blood Glucose Increased
Start date: 2005-01-01
End date: 2007-05-16
Lyrica
Indication: Neuropathy
Start date: 2005-01-01
End date: 2007-05-25
Other drugs received by patient: Toprol-XL; Glucophage; Lasix; Lipitor; Fenofibrate; Protonix; Plavix; Acetylsalicylic Acid SRT
Adverse event in 73 year old female receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification from France on 2007-06-06
Patient: 73 year old female
Adverse reactions / side effects: Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Drug Toxicity, Malaise, Overdose, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Hypoglycaemic Coma, Blood Creatinine Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, Cytolytic Hepatitis, Aspartate Aminotransferase Increased, Hyperthyroidism
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg, qd
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2007-02-05
Cotareg
Dosage: 1 df, qd
Administration route: Oral
Indication: Hypertension
End date: 2007-02-06
Tahor
Dosage: 1 df, qd
Administration route: Oral
End date: 2007-02-25
Other drugs received by patient: Rivotril; Zyprexa; Levothyroxine Sodium; Paracetamol
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-06-06
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 73 year old female receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from France on 2007-06-01
Patient: 73 year old female
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Hypoglycaemic Coma, Hepatic Enzyme Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Cotareg
Dosage: text:every day
Administration route: Oral
Indication: Essential Hypertension
Tahor
Administration route: Oral
Other drugs received by patient: Rivotril; Zyprexa; Levothyroxine Sodium
Adverse event in 46 year old male receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-05-25
Patient: 46 year old male
Adverse reactions / side effects: Gastroenteritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Start date: 2006-07-13
Blinded: Liraglutide
Indication: Diabetes Mellitus
Start date: 2006-08-04
Blinded: Placebo
Indication: Diabetes Mellitus
Start date: 2006-08-04
Metformin HCL
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2006-07-13
Other drugs received by patient: Aspirin
Page 1 Next >>
|
